CL2021003348A1 - Derivados de piridin–3–ilo. - Google Patents

Derivados de piridin–3–ilo.

Info

Publication number
CL2021003348A1
CL2021003348A1 CL2021003348A CL2021003348A CL2021003348A1 CL 2021003348 A1 CL2021003348 A1 CL 2021003348A1 CL 2021003348 A CL2021003348 A CL 2021003348A CL 2021003348 A CL2021003348 A CL 2021003348A CL 2021003348 A1 CL2021003348 A1 CL 2021003348A1
Authority
CL
Chile
Prior art keywords
pyridin
derivatives
formula
modulators
pharmaceuticals
Prior art date
Application number
CL2021003348A
Other languages
English (en)
Inventor
Martin Bolli
Christine Brotschi
Cyrille Lescop
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of CL2021003348A1 publication Critical patent/CL2021003348A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a derivados de piridin–3–ilo de Fórmula (I), en donde R1, R2, R3, R4, R5, Ar1, L, m y n son como se describen en la descripción, su preparación, a sales farmacéuticamente aceptables de los mismos, y a su uso como productos farmacéuticos, a composiciones farmacéuticas que contienen uno o más compuestos de Fórmula (I), y especialmente a su uso como moduladores del receptor LPA1.
CL2021003348A 2019-06-18 2021-12-15 Derivados de piridin–3–ilo. CL2021003348A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP2019065963 2019-06-18

Publications (1)

Publication Number Publication Date
CL2021003348A1 true CL2021003348A1 (es) 2022-09-23

Family

ID=71105482

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2021003348A CL2021003348A1 (es) 2019-06-18 2021-12-15 Derivados de piridin–3–ilo.

Country Status (14)

Country Link
US (1) US20220251068A1 (es)
EP (1) EP3986884A1 (es)
KR (1) KR20220020921A (es)
AR (1) AR119162A1 (es)
AU (1) AU2020298014A1 (es)
BR (1) BR112021025236A2 (es)
CA (1) CA3143618A1 (es)
CL (1) CL2021003348A1 (es)
IL (1) IL288950A (es)
MA (1) MA56504A (es)
MX (1) MX2021015727A (es)
SG (1) SG11202111162PA (es)
TW (1) TW202115011A (es)
WO (1) WO2020254408A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220109439A (ko) * 2019-12-04 2022-08-04 이도르시아 파마슈티컬스 리미티드 섬유증 질환의 치료에서 사용하기 위한 아제티딘 lpa1 수용체 길항제와 피르페니돈 및/또는 닌테다닙의 조합

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1364659B1 (en) 2001-02-08 2009-11-11 Ono Pharmaceutical Co., Ltd. Remedies for urinary diseases comprising lpa receptor controlling agents
TW200403058A (en) 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
JPWO2005037269A1 (ja) 2003-10-21 2006-12-28 住友製薬株式会社 新規ピペリジン誘導体
MXPA06005550A (es) 2003-11-18 2006-08-17 Warner Lambert Co Agentes antibacterianos.
WO2007023768A1 (ja) 2005-08-24 2007-03-01 Eisai R & D Management Co., Ltd. 新規ピリジン誘導体およびピリミジン誘導体（３）
JP5164510B2 (ja) 2006-10-06 2013-03-21 日本曹達株式会社 含窒素複素環化合物および有害生物防除剤
AU2008311971A1 (en) 2007-10-18 2009-04-23 Merck Sharp & Dohme Corp. Quinolizidinone M1 receptor positive allosteric modulators
PT2303270T (pt) 2008-05-05 2017-08-25 Sanofi Sa Derivados fundidos do ácido ciclopentanocarboxílico substituídos por acilamino e sua utilização como produtos farmacêuticos
PT2481725E (pt) * 2009-09-25 2015-05-21 Astellas Pharma Inc Composto de amida substituído
EP2601190B1 (en) 2010-08-05 2018-07-04 Zoetis Services LLC Isoxazoline derivatives as antiparasitic agents
TW201305178A (zh) 2010-10-29 2013-02-01 Glenmark Pharmaceuticals Sa 作為ｍＰＧＥＳ－１抑制物的三環化合物
NO2648726T3 (es) 2010-12-07 2018-09-01
ME02412B (me) 2011-03-10 2016-09-20 Zoetis Services Llc Spirociklični derivati izoksazolina kao antiparazitska sredstva
EP2794576A1 (en) 2011-12-21 2014-10-29 Ardelyx, Inc. Non-systemic tgr5 agonists
TW202016090A (zh) * 2018-06-07 2020-05-01 瑞士商愛杜西亞製藥有限公司 經烷氧基取代之吡啶基衍生物

Also Published As

Publication number Publication date
CN114026082A (zh) 2022-02-08
AU2020298014A1 (en) 2022-02-10
US20220251068A1 (en) 2022-08-11
EP3986884A1 (en) 2022-04-27
WO2020254408A1 (en) 2020-12-24
BR112021025236A2 (pt) 2022-02-01
MX2021015727A (es) 2022-01-24
CA3143618A1 (en) 2020-12-24
SG11202111162PA (en) 2021-11-29
TW202115011A (zh) 2021-04-16
MA56504A (fr) 2022-04-27
AR119162A1 (es) 2021-12-01
KR20220020921A (ko) 2022-02-21
JP2022537177A (ja) 2022-08-24
IL288950A (en) 2022-02-01

Similar Documents

Publication Publication Date Title
CO2019010804A2 (es) Derivados de indol n–sustituidos
CL2018001325A1 (es) Derivados de indol n-sustituidos como moduladores del receptor de pge2
MD3405471T2 (ro) Noi derivați de amoniu, procedeu pentru prepararea acestora și compoziții farmaceutice care îi conțin
CL2019003281A1 (es) Derivados de piperidina. (divisional solicitud 201900169)
MD3468974T2 (ro) Noi derivați de piperidinil, procedeu pentru prepararea lor și compoziții farmaceutice care ii conțin
CL2020001817A1 (es) Moduladores del receptor c5a
CL2019003275A1 (es) Derivados de pirimidina como moduladores del receptor de pge2.
ECSP088603A (es) Nuevas n-(fluor-pirazinil)-fenilsulfonamidas como moduladores del receptor de quimioquina ccr4
PH12015502632A1 (en) Cxcr7 receptor modulators
CL2022003646A1 (es) Derivados de amidopirimidona
CL2017002498A1 (es) Piridopirimidinonas y su uso como modulares del receptor nmda
DOP2021000103A (es) Pirazoles como moduladores de hemoglobina
CL2022000893A1 (es) Derivados de 2-azaspiro[3,4]octano como agonistas de m4
CL2021003348A1 (es) Derivados de piridin–3–ilo.
ECSP22027784A (es) Derivados de 2–azaespiro[3.4]octano como agonistas de m4
CO2021004553A2 (es) Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
EA202092955A1 (ru) Алкоксизамещенные пиридинильные производные в качестве антагонистов рецепторов lpa1 и их применение для лечения фиброза
ECSP099679A (es) Nuevos compuestos y sus usos 707
UY37968A (es) Derivados del tetrazolilpropilo y su uso como fungicidas
UY38108A (es) Derivados de 1-(5-sustituido imidazol-1-il)but-3-en y sus usos como fungicidas
MX2020014327A (es) Nuevos derivados de amino-pirimidonilo un proceso para su preparacion y composiciones farmaceuticas que los contienen.
CL2023000970A1 (es) Espiro derivados de alfa-d-galactopiranosidos
CL2023001138A1 (es) Derivados de 2-hidroxicicloalcan-1-carbamoilo inhibidores de galectina-3
CL2023002322A1 (es) Derivados de hidroxiheterocicloalquil-carbamoilo
UY38217A (es) Derivados de 1-imidazotiadiazol-2h-pirrol-5-ona